• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解码共济失调蛋白2磷酸密码:疾病中的结构见解与治疗机会

Decoding ATXN2 Phosphocode: Structural Insights and Therapeutic Opportunities in Disease.

作者信息

Kalasa Anil Kumar Apoorva Pai, Subair Suhail, Basthikoppa Shivamurthy Prathik, Ummar Samseera, Rajeev Athira C, Raju Rajesh

机构信息

Yenepoya University, Mangalore, India.

出版信息

Protein J. 2025 Aug 30. doi: 10.1007/s10930-025-10287-4.

DOI:10.1007/s10930-025-10287-4
PMID:40884740
Abstract

Ataxin-2 (ATXN2), a key RNA-binding protein, regulates RNA metabolism, stress granule formation, and neuronal homeostasis, with dysregulated phosphorylation contributing to Spinocerebellar Ataxia type 2 (SCA2), amyotrophic lateral sclerosis (ALS), and cancer. This review integrates structural biology, phosphoproteomics, and interactome analyses to map six critical phosphosites (S772, T741, S624, S684, S784, S889) within ATXN2's intrinsically disordered regions. Modulated by kinases GSK3β and CDK13 and phosphatases like INPP5F, these sites orchestrate interactions with RNA-binding partners (e.g., ATXN2L, FXR2, STAU2) and co-regulated proteins (e.g., TP53BP1, NUP153), driving pathogenesis through disrupted autophagy, nucleocytoplasmic transport, and stress granule dynamics. We propose targeted therapies, including GSK3β inhibitors for ALS, antisense oligonucleotides for SCA2, and MTOR modulators for cancer, to restore ATXN2 function. By elucidating phosphocode of ATXN2, this work highlights novel avenues for precision medicine in neurodegenerative and oncogenic diseases.

摘要

ataxin-2(ATXN2)是一种关键的RNA结合蛋白,可调节RNA代谢、应激颗粒形成和神经元稳态,磷酸化失调会导致2型脊髓小脑共济失调(SCA2)、肌萎缩侧索硬化症(ALS)和癌症。本综述整合了结构生物学、磷酸化蛋白质组学和相互作用组分析,以绘制ATXN2内在无序区域内的六个关键磷酸化位点(S772、T741、S624、S684、S784、S889)。这些位点受激酶GSK3β和CDK13以及诸如INPP5F等磷酸酶的调节,协调与RNA结合伙伴(如ATXN2L、FXR2、STAU2)和共同调节蛋白(如TP53BP1、NUP153)的相互作用,通过破坏自噬、核质运输和应激颗粒动力学来驱动发病机制。我们提出了靶向治疗方法,包括用于ALS的GSK3β抑制剂、用于SCA2的反义寡核苷酸和用于癌症的mTOR调节剂,以恢复ATXN2功能。通过阐明ATXN2的磷酸化密码,这项工作突出了神经退行性疾病和致癌疾病精准医学的新途径。

相似文献

1
Decoding ATXN2 Phosphocode: Structural Insights and Therapeutic Opportunities in Disease.解码共济失调蛋白2磷酸密码:疾病中的结构见解与治疗机会
Protein J. 2025 Aug 30. doi: 10.1007/s10930-025-10287-4.
2
ATXN2L primarily interacts with NUFIP2, the absence of ATXN2L results in NUFIP2 depletion, and the ATXN2-polyQ expansion triggers NUFIP2 accumulation.ATXN2L主要与NUFIP2相互作用,ATXN2L的缺失导致NUFIP2耗竭,而ATXN2的多聚谷氨酰胺扩展引发NUFIP2积累。
Neurobiol Dis. 2025 Jun 1;209:106903. doi: 10.1016/j.nbd.2025.106903. Epub 2025 Apr 11.
3
The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.多聚谷氨酰胺蛋白 ATXN2:从其分子功能到其在疾病中的作用。
Cell Death Dis. 2024 Jun 14;15(6):415. doi: 10.1038/s41419-024-06812-5.
4
Spinocerebellar ataxia type 2 followed by amyotrophic lateral sclerosis due to a pure CAG repeat expansion in ATXN2: a case report and literature review.2型脊髓小脑共济失调继发肌萎缩侧索硬化症,由ATXN2基因中单纯的CAG重复序列扩增所致:一例报告及文献综述
Neurol Sci. 2025 Jun 29. doi: 10.1007/s10072-025-08332-2.
5
An observational study of pleiotropy and penetrance of amyotrophic lateral sclerosis associated with CAG-repeat expansion of ATXN2.一项关于与ATXN2基因CAG重复序列扩增相关的肌萎缩侧索硬化症的多效性和外显率的观察性研究。
Eur J Hum Genet. 2025 Feb 16. doi: 10.1038/s41431-025-01811-2.
6
RNA Toxicity and Perturbation of rRNA Processing in Spinocerebellar Ataxia Type 2.RNA 毒性和小脑共济失调 2 型中 rRNA 加工的扰乱。
Mov Disord. 2021 Nov;36(11):2519-2529. doi: 10.1002/mds.28729. Epub 2021 Aug 14.
7
ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.ATXN2-AS是与ATXN2基因互补的反义基因,与2型脊髓小脑共济失调和肌萎缩侧索硬化症相关。
Ann Neurol. 2016 Oct;80(4):600-15. doi: 10.1002/ana.24761.
8
Influence of ATXN2 intermediate CAG repeats, 9bp duplication and alternative splicing on SCA3 pathogenesis.共济失调蛋白2基因中间CAG重复序列、9bp重复及可变剪接对脊髓小脑共济失调3型发病机制的影响。
Acta Neuropathol Commun. 2025 Jul 19;13(1):157. doi: 10.1186/s40478-025-02074-0.
9
ALS-associated genes in SCA2 mouse spinal cord transcriptomes.SCA2 小鼠脊髓转录组中的 ALS 相关基因。
Hum Mol Genet. 2020 Jun 27;29(10):1658-1672. doi: 10.1093/hmg/ddaa072.
10
AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALS.基于腺相关病毒载体递送靶向ataxin-2的RNA干扰可改善快速和缓慢进展性散发性肌萎缩侧索硬化症小鼠模型的存活率、肌肉力量及病理状况。
bioRxiv. 2024 Feb 2:2024.01.31.578314. doi: 10.1101/2024.01.31.578314.

本文引用的文献

1
Implications of Mutant SOD1 on RNA Processing and Interferon Responses in Amyotrophic Lateral Sclerosis: Omics Data Analysis.突变型超氧化物歧化酶1对肌萎缩侧索硬化症中RNA加工和干扰素反应的影响:组学数据分析
Cureus. 2025 Mar 23;17(3):e81045. doi: 10.7759/cureus.81045. eCollection 2025 Mar.
2
ATXN2L primarily interacts with NUFIP2, the absence of ATXN2L results in NUFIP2 depletion, and the ATXN2-polyQ expansion triggers NUFIP2 accumulation.ATXN2L主要与NUFIP2相互作用,ATXN2L的缺失导致NUFIP2耗竭,而ATXN2的多聚谷氨酰胺扩展引发NUFIP2积累。
Neurobiol Dis. 2025 Jun 1;209:106903. doi: 10.1016/j.nbd.2025.106903. Epub 2025 Apr 11.
3
5-Repurposed Drug Candidates Identified in Motor Neurons and Muscle Tissues with Amyotrophic Lateral Sclerosis by Network Biology and Machine Learning Based on Gene Expression.
基于基因表达,通过网络生物学和机器学习在肌萎缩侧索硬化症的运动神经元和肌肉组织中鉴定出5种重新利用的候选药物。
Neuromolecular Med. 2025 Apr 3;27(1):24. doi: 10.1007/s12017-025-08847-z.
4
Orchestrating Intracellular Calcium Signaling Cascades by Phosphosite-Centric Regulatory Network: A Comprehensive Analysis on Kinases CAMKK1 and CAMKK2.通过以磷酸化位点为中心的调控网络编排细胞内钙信号级联:对激酶CAMKK1和CAMKK2的全面分析
OMICS. 2025 Apr;29(4):139-153. doi: 10.1089/omi.2024.0196. Epub 2025 Mar 12.
5
Staufen2 dysregulation in neurodegenerative disease.神经退行性疾病中Staufen2的失调
J Biol Chem. 2025 Mar;301(3):108316. doi: 10.1016/j.jbc.2025.108316. Epub 2025 Feb 13.
6
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease.细胞周期蛋白依赖性蛋白激酶与生物学和疾病中的细胞周期调控
Signal Transduct Target Ther. 2025 Jan 13;10(1):11. doi: 10.1038/s41392-024-02080-z.
7
CTDSPL2 promotes the progression of non-small lung cancer through PI3K/AKT signaling via JAK1.CTDSPL2通过JAK1经由PI3K/AKT信号通路促进非小细胞肺癌的进展。
Cell Death Discov. 2024 Aug 29;10(1):389. doi: 10.1038/s41420-024-02162-5.
8
The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.多聚谷氨酰胺蛋白 ATXN2:从其分子功能到其在疾病中的作用。
Cell Death Dis. 2024 Jun 14;15(6):415. doi: 10.1038/s41419-024-06812-5.
9
A global phosphosite-correlated network map of Thousand And One Kinase 1 (TAOK1).千一激酶 1(TAOK1)的全球磷酸化位点相关网络图谱。
Int J Biochem Cell Biol. 2024 May;170:106558. doi: 10.1016/j.biocel.2024.106558. Epub 2024 Mar 11.
10
eEF1A2 promotes PTEN-GSK3β-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer.eEF1A2 促进 PTEN-GSK3β-SCF 复合物依赖性降解 Aurora 激酶 A,并在乳腺癌中失活。
Sci Signal. 2024 Mar 5;17(826):eadh4475. doi: 10.1126/scisignal.adh4475.